Oppenheimer Asset Management Inc. Has $5.88 Million Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Oppenheimer Asset Management Inc. raised its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 9.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 261,918 shares of the company's stock after purchasing an additional 21,590 shares during the quarter. Oppenheimer Asset Management Inc. owned approximately 0.22% of Privia Health Group worth $5,880,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Loomis Sayles & Co. L P lifted its holdings in shares of Privia Health Group by 55.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock worth $27,727,000 after buying an additional 503,002 shares in the last quarter. Durable Capital Partners LP increased its position in Privia Health Group by 3.4% during the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company's stock worth $224,587,000 after acquiring an additional 378,255 shares during the period. BlackBarn Capital Partners LP raised its stake in Privia Health Group by 65.8% in the 4th quarter. BlackBarn Capital Partners LP now owns 663,397 shares of the company's stock worth $12,969,000 after purchasing an additional 263,397 shares in the last quarter. Nuveen Asset Management LLC raised its stake in Privia Health Group by 19.8% in the 4th quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company's stock worth $29,110,000 after purchasing an additional 246,393 shares in the last quarter. Finally, BNP Paribas Financial Markets acquired a new stake in Privia Health Group in the 4th quarter worth about $4,321,000. Institutional investors and hedge funds own 94.48% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on PRVA shares. JPMorgan Chase & Co. lifted their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 28th. Piper Sandler lifted their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, February 28th. JMP Securities reiterated a "market outperform" rating and issued a $29.00 price objective on shares of Privia Health Group in a research note on Monday, April 28th. Barclays lifted their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a research note on Tuesday, May 27th. Finally, Canaccord Genuity Group lifted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $27.77.

Insider Activity

In related news, Director Matthew Shawn Morris sold 10,309 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $240,508.97. Following the completion of the transaction, the director now directly owns 59,792 shares in the company, valued at $1,394,947.36. This represents a 14.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now owns 179,676 shares of the company's stock, valued at approximately $4,021,148.88. This represents a 3.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 51,579 shares of company stock worth $1,226,367. 10.70% of the stock is currently owned by corporate insiders.

Privia Health Group Trading Up 1.9%

Shares of NASDAQ:PRVA opened at $22.01 on Wednesday. The firm has a 50 day moving average of $23.27 and a 200-day moving average of $22.85. The stock has a market capitalization of $2.68 billion, a PE ratio of 183.43, a PEG ratio of 3.46 and a beta of 0.83. Privia Health Group, Inc. has a 12 month low of $16.37 and a 12 month high of $26.09.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.